Collaborative Study to Establish National Reference Standards for Anti-HIV-1 Antibody

BACKGROUND: National reference standards for anti-HIV-1 antibody are needed to evaluate the performance and maintain the quality control of anti-HIV-1 antibody assays.

The aim of this study was to prepare a mixed-titer performance panel and assess its suitability as a national reference standard for anti-HIV-1 antibody according to stability, collaboration, and other studies.

METHODS: Nineteen serum samples from different HIV patients were obtained, along with 15 units of fresh frozen plasma samples with negative anti-HIV-1 antibody results.

Ten anti- HIV-1 antibody-positive candidate standards and two negative candidate standards were prepared based on the reactivity in the Alinity i HIV Ag/Ab combo assay (Abbott Laboratories, Wiesbaden, Germany).

A collaborative study was conducted across eight laboratories using five anti-HIV-1 antibody assays.

Real-time and accelerated stability were evaluated to assess the long-term stability.

RESULTS: In the collaborative study, results of all five anti-HIV-1 antibody assays were positive for all 10 candidate standards prepared using HIV patient samples.

The CV of each assay for every candidate standard was within 10%, except for one assay result.

No real-time and accelerated stability change trend was observed at −70°C or −20°C, supporting that the reference standards were maintained in a stable state at −70°C for long-term storage.

CONCLUSIONS: The overall results suggest that the 12 candidate standards could serve as national reference standards for anti-HIV-1 antibody.